Japanese personal care firm Shiseido has entered into an agreement to acquire all of the outstanding shares of Gallinée, a London-based beauty brand dedicated to caring for the skin’s microbiome from head-to-toe.
Gallinée was founded in 2014 by Marie Drago, PharmD, a specialist in the skin microbiome. The brand offers a range of science-backed beauty products featuring a patented complex of prebiotics, probiotics and postbiotics that nourish and strengthen the skin’s microbiome.
Following the transaction, Drago will join Shiseido’s EMEA team and continue to deliver product innovation and support Gallinée as the chief creative officer of the brand, reporting directly to Franck Marilly, President and CEO of Shiseido EMEA & Global Fragrance.
“Gallinée will deliver a complementary yet unique addition to Shiseido’s existing portfolio given its focus on beauty and wellness as well as its differentiated positioning within the emerging field of skin microbiome,” said Shiseido in a statement.
“As part of Shiseido group, Gallinée will be able to leverage resources across our commercial infrastructure, extensive R&D capabilities especially from our European Innovation Centre to lead the development of the skin microbiome within the EMEA territory, and cross-functional expertise to continue to drive brand growth,” it added.
